10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership2,588,795 shares
Latest Disclosed Value $ 54,960,118
State Street Corp reports 3.04% increase in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 2,588,795 shares of 10x Genomics, Inc. (MX:TXG) valued at $54,960,118 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,512,519 shares of 10x Genomics, Inc.. This represents a change in shares of 3.04% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 2,588,795 76,276 3.04 54,960 34.12 0.0019
2026-02-13 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 2,512,519 -7,680 -0.30 40,979 39.10 0.0014
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 2,520,199 27,523 1.10 29,461 2.06 0.0010
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 2,492,676 680,475 37.55 28,865 82.46 0.0011
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 1,812,201 37,209 2.10 15,821 -37.93 0.0007
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 1,774,992 24,349 1.39 25,489 -35.52 0.0010
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 1,750,643 116,534 7.13 39,530 24.37 0.0016
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 1,634,109 48,407 3.05 31,783 -46.59 0.0014
2024-05-15 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 1,585,702 26,474 1.70 59,511 -31.80 0.0027
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 1,559,228 98,591 6.75 87,254 44.82 0.0042
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 1,460,637 28,100 1.96 60,251 -24.68 0.0033
2023-08-14 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 1,432,537 20,190 1.43 79,993 1.52 0.0042
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 1,412,347 66,598 4.95 78,792 60.67 0.0044
2023-05-15 2022-12-31 13F/A-99 10X GENOMICS CL A COM 88025U109 1,345,749 -18,168 -1.33 49,039 26.25 0.0029
2023-05-15 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 1,345,749 -18,168 49,039 0.0029
2022-11-15 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 1,363,917 26,695 2.00 38,844 -35.80 0.0025
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 1,337,222 -345,543 -20.53 60,509 -52.73 0.0036
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 1,682,765 16,343 0.98 128,008 -48.43 0.0063
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 1,666,422 -1,214 -0.07 248,230 2.25 0.0118
2021-11-15 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 1,667,636 73,616 4.62 242,774 -22.22 0.0128
2021-08-16 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 1,594,020 463,597 41.01 312,141 52.56 0.0165
2021-07-09 2021-03-31 13F/A-1 10X GENOMICS CL A COM 88025U109 1,130,423 58,876 5.49 204,607 34.85 0.0117
2021-05-17 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 1,130,423 58,876 204,607 0.0117
2021-02-16 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 1,071,547 508,153 90.19 151,731 116.01 0.0093
2020-11-10 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 563,394 71,404 14.51 70,244 59.86 0.0048
2020-08-14 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 491,990 484,890 6,829.44 43,940 9,841.18 0.0032
2020-06-19 2020-03-31 13F/A-1 10X GENOMICS CL A COM 88025U109 7,100 2,400 51.06 442 23.46 0.0000
2020-05-11 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 7,100 2,400 442 38.8165
2020-02-06 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 4,700 4,700 358 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.